The SCOUT study, which began in 2002, was designed to show that weight loss with sibutramine and standard care was more effective in reducing the number of cardiovascular events compared to weight loss from a placebo and standard care. About 10,000 overweight or obese people, 55 years of age or older, who had a history of heart disease or type 2 diabetes plus one additional cardiovascular risk factor were enrolled in the study. Patients who recently had a heart attack or stroke, or had poorly controlled congestive heart failure were not included.
No comments:
Post a Comment